Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 4;71(44):1418-1424.
doi: 10.15585/mmwr.mm7144e2.

Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case - New York, March 9-October 11, 2022

Collaborators, Affiliations
Case Reports

Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case - New York, March 9-October 11, 2022

A Blythe Ryerson et al. MMWR Morb Mortal Wkly Rep. .

Abstract

In July 2022, a case of paralytic poliomyelitis resulting from infection with vaccine-derived poliovirus (VDPV) type 2 (VDPV2)§ was confirmed in an unvaccinated adult resident of Rockland County, New York (1). As of August 10, 2022, poliovirus type 2 (PV2) genetically linked to this VDPV2 had been detected in wastewater** in Rockland County and neighboring Orange County (1). This report describes the results of additional poliovirus testing of wastewater samples collected during March 9-October 11, 2022, and tested as of October 20, 2022, from 48 sewersheds (the community area served by a wastewater collection system) serving parts of Rockland County and 12 surrounding counties. Among 1,076 wastewater samples collected, 89 (8.3%) from 10 sewersheds tested positive for PV2. As part of a broad epidemiologic investigation, wastewater testing can provide information about where poliovirus might be circulating in a community in which a paralytic case has been identified; however, the most important public health actions for preventing paralytic poliomyelitis in the United States remain ongoing case detection through national acute flaccid myelitis (AFM) surveillance†† and improving vaccination coverage in undervaccinated communities. Although most persons in the United States are sufficiently immunized, unvaccinated or undervaccinated persons living or working in Kings, Orange, Queens, Rockland, or Sullivan counties, New York should complete the polio vaccination series as soon as possible.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Kirsten St. George and Meghan Fuschino report institutional support from ThermoFisher; royalty-generating collaborative research agreement with Zeptometrix, with payments to institution; and receipt of digital polymerase chain reaction equipment for public health testing purposes from QIAgen. Nancy McGraw reports an uncompensated leadership in the New York State Association of County Health Officials. Andrew Knecht reports uncompensated membership on the editorial board of the American Journal of Preventive Medicine–Focus. Daniel Lang reports uncompensated membership on the New York State Water Quality Council. No other potential conflicts of interest were disclosed.

Figures

FIGURE 1
FIGURE 1
Wastewater polio test results, by jurisdiction (N = 1,053) — 13 counties in New York and New York City, March 9–October 11, 2022 Abbreviation: PV2 = poliovirus type 2. * Sampling sites are sewersheds defined as the community area served by a wastewater collection system. Testing was conducted to determine if a sample was negative or positive for PV2, and if positive for PV2, whether the PV2 was genetically linked to an unvaccinated paralytic poliomyelitis patient from Rockland County, New York identified in July 2022. Some samples had sequencing insufficient to determine relation to the Rockland County patient (i.e., linkage to patient unknown). Indeterminate results are excluded from this figure. Indeterminate results include those from samples that tested positive using real-time reverse transcription polymerase chain reaction, but not enough viral material was available to complete sequencing. Specimens pending sequencing results are also excluded. § Number of samples in each jurisdiction include New York City (408) and the following New York counties: Rockland (124), Putnam (20), Orange (280), Nassau (85), Sullivan (21), Westchester (83), Suffolk (14), and Ulster (18).
FIGURE 2
FIGURE 2
Sewersheds with detections of poliovirus type 2 genetically linked to the virus isolated from a paralytic polio patient — Sullivan (A), Orange (B), Rockland (C), Kings and Queens (D), and Nassau (E) counties, New York, March 9–October 11, 2022 Abbreviation: PV2 = poliovirus type 2. * Sampling sites are sewersheds defined as the community area served by a wastewater collection system. Sub-sewersheds are upstream sampling locations within a larger sewershed. In July 2022, paralytic poliomyelitis resulting from infection with vaccine-derived PV2 was confirmed in an unvaccinated adult resident of Rockland County, New York. § A single large-volume sample from a sub-sewershed serving parts of Kings and Queens counties tested positive for the PV2 genetically linked to the virus isolated from the patient.

References

    1. Link-Gelles R, Lutterloh E, Schnabel Ruppert P, et al. ; 2022 U.S. Poliovirus Response Team. Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater—New York, June–August 2022. MMWR Morb Mortal Wkly Rep 2022;71:1065–8. 10.15585/mmwr.mm7133e2 - DOI - PMC - PubMed
    1. Hill HA, Yankey D, Elam-Evans LD, Singleton JA, Sterrett N. Vaccination coverage by age 24 months among children born in 2017 and 2018—National Immunization Survey-Child, United States, 2018–2020. MMWR Morb Mortal Wkly Rep 2021;70:1435–40. 10.15585/mmwr.mm7041a1 - DOI - PMC - PubMed
    1. McBean AM, Thoms ML, Albrecht P, Cuthie JC, Bernier R. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. Am J Epidemiol 1988;128:615–28. 10.1093/oxfordjournals.aje.a115009 - DOI - PubMed
    1. Gerloff N, Sun H, Mandelbaum M, et al. Diagnostic assay development for poliovirus eradication. J Clin Microbiol 2018;56:e01624–17. 10.1128/JCM.01624-17 - DOI - PMC - PubMed
    1. Sun H, Harrington C, Gerloff N, et al. Validation of a redesigned pan-poliovirus assay and real-time PCR platforms for the global poliovirus laboratory network. PLoS One 2021;16:e0255795. 10.1371/journal.pone.0255795 - DOI - PMC - PubMed

Publication types